United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Pharma Industry News Bio-Path Holdings unveils preclinical success for BP1001-A in treating obesity and Type 2 diabetes Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology innovator known for leveraging its DNAbilize liposomal delivery platform, has announced… byPallavi MadhirajuDecember 19, 2024